PIK3C3 and neoplasm: As a member of the class III phosphoinositide 3-kinase (PI3K) family, PIK3C3 plays a critical role in the regulation of autophagy (49), and its mutation may disrupt metabolic homeostasis in tumor cells, potentially offering a novel avenue for targeted therapy (50).